Rini, Brian I.
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University,
United States
2025 Rank: 4,132
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 100 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4,132 | 4,039 |
| Total Cites | 4,367 | 4,777 |
| H-index | 30 | 31 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 27 | 27 |
| Number of Single+First Authored Papers | 136 | 136 |
| Total Cites to Single+First Authored Papers | 856 | 896 |
| Number of Single+First+Last Authored Papers | 263 | 263 |
| Total Cites to Single+First+Last Authored Papers | 1,493 | 1,572 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,400 | 2,479 |
| Ratio of Total Citations to Distinct Citing Papers | 1.82 | 1.93 |
| Self-Citation Percentage |
8.58%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 56 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1,949 | 1,895 |
| Total Cites | 5,782 | 6,459 |
| H-index | 33 | 35 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 35 | 35 |
| Number of Single+First Authored Papers | 134 | 134 |
| Total Cites to Single+First Authored Papers | 1,170 | 1,266 |
| Number of Single+First+Last Authored Papers | 249 | 249 |
| Total Cites to Single+First+Last Authored Papers | 1,951 | 2,120 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,080 | 3,223 |
| Ratio of Total Citations to Distinct Citing Papers | 1.88 | 2.00 |
| Self-Citation Percentage |
10.48%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 121 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3,531 | 3,705 |
| Total Cites | 3,969 | 4,371 |
| H-index | 27 | 28 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 33 | 33 |
| Number of Single+First Authored Papers | 123 | 123 |
| Total Cites to Single+First Authored Papers | 965 | 1,021 |
| Number of Single+First+Last Authored Papers | 216 | 216 |
| Total Cites to Single+First+Last Authored Papers | 1,334 | 1,411 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,201 | 2,296 |
| Ratio of Total Citations to Distinct Citing Papers | 1.80 | 1.90 |
| Self-Citation Percentage |
9.20%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 109 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3,208 | 3,160 |
| Total Cites | 4,264 | 4,790 |
| H-index | 30 | 32 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 46 | 47 |
| Number of Single+First Authored Papers | 124 | 124 |
| Total Cites to Single+First Authored Papers | 983 | 1,049 |
| Number of Single+First+Last Authored Papers | 219 | 219 |
| Total Cites to Single+First+Last Authored Papers | 1,470 | 1,578 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,311 | 2,427 |
| Ratio of Total Citations to Distinct Citing Papers | 1.85 | 1.97 |
| Self-Citation Percentage |
10.98%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.